These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 4339577)
61. [True and false adverse effects of thymoanaleptic medications]. Lajeunesse BS Sem Hop; 1968 Dec; 44(51):3161-4. PubMed ID: 4308278 [No Abstract] [Full Text] [Related]
62. The antagonism of amphetamine-induced symptomatology by a neuroleptic. Angrist B; Lee HK; Gershon S Am J Psychiatry; 1974 Jul; 131(7):817-9. PubMed ID: 4600629 [No Abstract] [Full Text] [Related]
63. Cocaine psychoses: a continuum model. Post RM Am J Psychiatry; 1975 Mar; 132(3):225-31. PubMed ID: 1115261 [TBL] [Abstract][Full Text] [Related]
64. Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic anti-depressant drugs. Scheel-Krüger J Eur J Pharmacol; 1972 Apr; 18(1):63-73. PubMed ID: 5031275 [No Abstract] [Full Text] [Related]
65. Proceedings: Pharmacology of the adrenergic mechanism. Pfeifer AK J Neural Transm; 1974; Suppl 11(0):163-80. PubMed ID: 4135935 [No Abstract] [Full Text] [Related]
66. Stimulus-dependent antagonism of the alpha-methyltyrosine-induced lowering of brain catecholamines by (+)-amphetamine in intact mice. Welch BL; Welch AS J Pharm Pharmacol; 1967 Dec; 19(12):841-3. PubMed ID: 4384230 [No Abstract] [Full Text] [Related]
67. The effect of dopamine and other catecholamines on neuromuscular transmission. Blum K Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):297-306. PubMed ID: 4326551 [No Abstract] [Full Text] [Related]
68. Amphetamine psychosis. Perry PJ; Juhl RP Am J Hosp Pharm; 1977 Aug; 34(8):883-5. PubMed ID: 900138 [TBL] [Abstract][Full Text] [Related]
69. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex. Heikkila RE; Orlansky H; Mytilineou C; Cohen G J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755 [TBL] [Abstract][Full Text] [Related]
70. [STP--(DOM), a psychomimetic amphetamine with hallucinogenic and psychosis-inducing properties]. Holsten F Tidsskr Nor Laegeforen; 1975 Feb; 95(4):234-7. PubMed ID: 1129722 [No Abstract] [Full Text] [Related]
71. [Effect of monoamine oxidase inhibitors on the content of catecholamines in different parts of the brain in cats]. Vysotskaia NB; Kaverina NV; Mirzoian RS; Rozonov IuB Farmakol Toksikol; 1967; 30(3):289-92. PubMed ID: 5597732 [No Abstract] [Full Text] [Related]
72. [Clinical psychopharmacology in 1971]. Vinar O Act Nerv Super (Praha); 1972; 14(2):141-60. PubMed ID: 4339153 [No Abstract] [Full Text] [Related]
73. Study on the mechanism of the metabolism increase by amphetamine and by the elevation of brain catecholamines. Pfeifer AK Act Nerv Super (Praha); 1972 Nov; 14(4):295-7. PubMed ID: 5083834 [No Abstract] [Full Text] [Related]
74. Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias. Rubovits R; Klawans HL Arch Gen Psychiatry; 1972 Oct; 27(4):502-7. PubMed ID: 5072718 [No Abstract] [Full Text] [Related]
75. [Monoamine oxidase inhibitors and anesthesia]. Iwatsuki K Masui; 1969 Oct; 18(10):905-17. PubMed ID: 4901683 [No Abstract] [Full Text] [Related]
76. Clinical response to several dopamine agonists in schizophrenic and nonschizophrenic subjects. Angrist B; Gershon S Adv Biochem Psychopharmacol; 1977; 16():677-80. PubMed ID: 883566 [No Abstract] [Full Text] [Related]